Skip to main content
. 2019 Feb 7;2019(2):CD012730. doi: 10.1002/14651858.CD012730.pub2

Comparison 10. Ciprofloxacin (500 mg twice daily) with infliximab versus placebo with infliximab.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Failure to achieve clinical response at week 12 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
2 Adverse events 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
3 Withdrawal due to adverse events 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected